Danaher strikes $4bn Cepheid deal
Reuters Danaher Corp said it would buy medical diagnostics company Cepheid in a deal valued at $4 billion, including debt, that will strengthen its presence in molecular diagnostics. Danaher, which develops technology for the dental, life sciences, diagnostics and environmental industries, spun off its industrial division in July to focus on science and technology. Piper Jaffray analysts said the ...
Read More »